|
WO2008033142A1
|
|
Bile preparations for colorectal disorders
|
|
KR20090059151A
|
|
Bile preparations for corlorectal disorders
|
|
AU2006203315A1
|
|
Preparation of aqueous clear solution dosage forms with bile acids
|
|
AU2005302452A1
|
|
Methods and compositions for reducing neurodegeneration in Amyotrophic Lateral Sclerosis
|
|
US2006089331A1
|
|
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
|
CN101039699A
|
|
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
|
AU2005279961A1
|
|
Neuroprotective effect of solubilized UDCA in focal ischemic model
|
|
BRPI0419213A
|
|
Dry forms of aqueous solubilized bile acid dosage formulation: preparation and uses of these
|
|
KR20070098821A
|
|
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
|
KR20060030125A
|
|
Aqueous clear solution comprising bile acids and extract of ginseng, preparation method thereof
|
|
US7303768B2
|
|
Preparation of aqueous clear solution dosage forms with bile acids
|
|
CN1450914A
|
|
Preparation contains the clear aqueous solution dosage form of bile acid
|
|
AU5081999A
|
|
Preparation of aqueous clear solution dosage forms with bile acids
|
|
BR9610288A
|
|
Amine acid salt compounds and process for their production
|
